// App-Quantinova.ai

394 : Predicting Venous Thromboembolism Recurrence Risk in Patients with Cancer: A Validation Study

Researchers

Presenter

  • Gauruv Bose

Principal Investigators

  • Andrew Cheung

  • Benjamin H Chin-Yee

  • Simon Wells

  • Philip S Wells

Medical Centers

  • Department of Medicine, Division of Hematology, University of Western Ontario -London Health Sciences Centre, London, ON, Canada

  • Department of Pathology, London Health Sciences Centre, London, ON, Canada

  • medicine, ottawa university, Ottawa, ON, Canada

  • Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada

  • University of Ottawa, Ottawa, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pulmonary embolism

  • Venous thrombosis

  • Deep vein thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Warfarin

  • Heparin

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim